Alan Cantor

23.5k total citations · 4 hit papers
286 papers, 17.8k citations indexed

About

Alan Cantor is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alan Cantor has authored 286 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 76 papers in Oncology and 46 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alan Cantor's work include Acute Myeloid Leukemia Research (21 papers), Breast Cancer Treatment Studies (21 papers) and Breast Lesions and Carcinomas (20 papers). Alan Cantor is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Breast Cancer Treatment Studies (21 papers) and Breast Lesions and Carcinomas (20 papers). Alan Cantor collaborates with scholars based in United States, Canada and France. Alan Cantor's co-authors include Stuart H. Orkin, Gerold Bepler, Yuko Fujiwara, George R. Simon, Charles E. Cox, Richard Jove, Swati Sharma, Jonghwan Kim, Garrett M. Brodeur and Thomas E. Akie and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Alan Cantor

281 papers receiving 17.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A

2008 668 citations Vijay G. Sankaran, Tobias Menne et al. Science profile →
Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human Neuroblastoma

1993 552 citations Alan Cantor et al. profile →
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

2005 524 citations Alan Cantor et al. Cancer profile →
A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs

2010 516 citations Andrew J. Woo, Yuko Fujiwara et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan Cantor United States	69	6.9k	4.6k	2.9k	2.6k	2.1k	286	17.8k
Michael S. Pepper South Africa	75	11.0k 1.6×	4.8k 1.0×	4.6k 1.6×	1.4k 0.6×	1.3k 0.6×	346	20.9k
Neil E. Caporaso United States	72	7.0k 1.0×	4.3k 0.9×	3.2k 1.1×	3.6k 1.4×	1.3k 0.6×	279	17.6k
Emile E. Voest Netherlands	70	7.3k 1.1×	8.5k 1.9×	4.9k 1.7×	3.1k 1.2×	1.4k 0.7×	370	18.8k
William D. Figg United States	86	11.5k 1.7×	10.0k 2.2×	3.4k 1.2×	4.4k 1.7×	1.8k 0.9×	604	25.3k
Howard L. McLeod United States	81	9.6k 1.4×	10.1k 2.2×	2.9k 1.0×	2.6k 1.0×	2.3k 1.1×	481	26.6k
Hans Jørgen Nielsen Denmark	58	3.4k 0.5×	4.2k 0.9×	2.7k 1.0×	1.5k 0.6×	1.3k 0.6×	390	12.1k
Patrice Viens France	61	6.0k 0.9×	10.5k 2.3×	5.6k 2.0×	2.8k 1.1×	1.2k 0.6×	353	17.5k
Bruce A. Chabner United States	66	5.3k 0.8×	5.3k 1.1×	1.6k 0.6×	2.1k 0.8×	2.7k 1.3×	284	16.9k
William E. Evans United States	93	9.4k 1.4×	6.7k 1.5×	1.8k 0.6×	1.8k 0.7×	1.7k 0.8×	386	34.0k
Richard S. Houlston United Kingdom	68	8.5k 1.2×	6.4k 1.4×	3.7k 1.3×	2.3k 0.9×	7.0k 3.4×	468	20.2k

Countries citing papers authored by Alan Cantor

Since Specialization

Citations

This map shows the geographic impact of Alan Cantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Cantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Cantor more than expected).

Fields of papers citing papers by Alan Cantor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Cantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Cantor. The network helps show where Alan Cantor may publish in the future.

Co-authorship network of co-authors of Alan Cantor

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Cantor. A scholar is included among the top collaborators of Alan Cantor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Cantor. Alan Cantor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wahlster, Lara, Lucy A. Godley, Jason X. Cheng, et al.. (2025). ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance. Blood. 146(2). 254–259.

Wahlster, Lara, Jared H. Rowe, Nina Weichert‐Leahey, et al.. (2024). Expanding the Morphologic Spectrum of ANKRD26-Related Thrombocytopenia-2: A Case Series. Blood. 144(Supplement 1). 5708–5708.

Wachter, Franziska, Hongyuan Luo, David A. Williams, et al.. (2022). Transient neonatal hemolytic anemia due to the novel gamma globin gene mutation HBG2:C.290T>C, p.Leu97Pro (hemoglobin Wareham). Pediatric Blood & Cancer. 70(1). e30067–e30067. 1 indexed citations

Wahlster, Lara, Jeffrey M. Verboon, Leif S. Ludwig, et al.. (2021). Familial thrombocytopenia due to a complex structural variant resulting in a WAC-ANKRD26 fusion transcript. The Journal of Experimental Medicine. 218(6). 10 indexed citations

Cantor, Alan, et al.. (2021). Opening the window for endothelial-to-hematopoietic transition. Genes & Development. 35(21-22). 1398–1400. 3 indexed citations

Hasle, Henrik, Ronald M. Kline, Eigil Kjeldsen, et al.. (2021). Germline GATA1s-generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype. Blood. 139(21). 3159–3165. 16 indexed citations

Bail, Jennifer R., Andrew D. Frugé, Mallory G. Cases, et al.. (2018). A home‐based mentored vegetable gardening intervention demonstrates feasibility and improvements in physical activity and performance among breast cancer survivors. Cancer. 124(16). 3427–3435. 58 indexed citations

Santos, Jennifer F. De Los, Alan Cantor, Keith D. Amos, et al.. (2013). Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Cancer. 119(10). 1776–1783. 152 indexed citations

Yu, Ming, Tali Mazor, Hui Huang, et al.. (2012). Direct Recruitment of Polycomb Repressive Complex 1 (PRC1) to Chromatin by Core Binding Transcription Factors. Europe PMC (PubMed Central). 160 indexed citations

10.

Grunda, Jessica M., John B. Fiveash, Cheryl A. Palmer, et al.. (2010). Rationally Designed Pharmacogenomic Treatment Using Concurrent Capecitabine and Radiotherapy for Glioblastoma; Gene Expression Profiles Associated with Outcome. Clinical Cancer Research. 16(10). 2890–2898. 25 indexed citations

11.

Sankaran, Vijay G., Tobias Menne, Jian Xu, et al.. (2008). Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A. Science. 322(5909). 1839–1842. 668 indexed citations breakdown →

12.

Woo, Andrew J., Tyler B. Moran, Yocheved L. Schindler, et al.. (2008). Identification of ZBP-89 as a Novel GATA-1-Associated Transcription Factor Involved in Megakaryocytic and Erythroid Development. Molecular and Cellular Biology. 28(8). 2675–2689. 56 indexed citations

13.

Simon, George R., Anupama Sharma, Xueli Li, et al.. (2007). Feasibility and Efficacy of Molecular Analysis-Directed Individualized Therapy in Advanced Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 25(19). 2741–2746. 147 indexed citations

14.

Extermann, Martine, G. Albrand, Hongbin Chen, et al.. (2003). Are Older French Patients As Willing As Older American Patients to Undertake Chemotherapy?. Journal of Clinical Oncology. 21(17). 3214–3219. 108 indexed citations

15.

Cantor, Alan. (2003). SAS survival analysis techniques for medical research. 53 indexed citations

16.

Jakub, James W., Mark Ebert, Nils M. Diaz, et al.. (2003). Effect of Lymphatic Mapping on Diagnosis and Treatment of Patients With T1a, T1b Favorable Breast Cancer. Annals of Surgery. 237(6). 838–843. 6 indexed citations

17.

Cantor, Alan, Samuel G. Katz, & Stuart H. Orkin. (2002). Distinct Domains of the GATA-1 Cofactor FOG-1 Differentially Influence Erythroid versus Megakaryocytic Maturation. Molecular and Cellular Biology. 22(12). 4268–4279. 77 indexed citations

18.

Alvarado, Carlos S., C. Kretschmar, V V Joshi, et al.. (1997). Chemotherapy for Patients with Recurrent or Refractory Neuroblastoma: A POG Phase II Study. The American journal of pediatric hematology/oncology. 19(1). 62–67. 13 indexed citations

19.

Weiner, Michael A., Brigid G. Leventhal, Martin L. Brecher, et al.. (1997). Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.. Journal of Clinical Oncology. 15(8). 2769–2779. 115 indexed citations

20.

Joshi, Vijay, Jan F. Silverman, Geoffrey Altshuler, et al.. (1993). Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: A report from the pediatric oncology group. Human Pathology. 24(5). 493–504. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact